Literature DB >> 28762652

HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay.

P Soodla1, R Simmons2, K Huik1, M Pauskar1, E-L Jõgeda1, H Rajasaar1, E Kallaste1, M Maimets3, R Avi1, G Murphy4, K Porter2, I Lutsar1.   

Abstract

OBJECTIVES: Estonia has one the highest number of new HIV diagnoses in the European Union, mainly among injecting drug users and heterosexuals. Little is known of HIV incidence, which is crucial for limiting the epidemic. Using a recent HIV infection testing algorithm (RITA) assay, we aimed to estimate HIV incidence in 2013.
METHODS: All individuals aged ≥18 years newly-diagnosed with HIV in Estonia January- December 2013, except blood donors and those undergoing antenatal screening, were included. Demographic and clinical data were obtained from the Estonian Health Board and the Estonian HIV-positive patient database. Serum samples were tested for recent infection using the LAg-avidity EIA assay. HIV incidence was estimated based on previously published methods.
RESULTS: Of 69,115 tested subjects, 286 (0.41%) were newly-diagnosed with HIV with median age of 33 years (IQR: 28-42) and 65% male. Self-reported routes of HIV transmission were mostly heterosexual contact (n = 157, 53%) and injecting drug use (n = 62, 21%); 64 (22%) were with unknown risk group. Eighty two (36%) were assigned recent, resulting in estimated HIV incidence of 0.06%, corresponding to 642 new infections in 2013 among the non-screened population. Incidence was highest (1.48%) among people who inject drugs.
CONCLUSIONS: These high HIV incidence estimates in Estonia call for urgent action of renewed targeted public health promotion and HIV testing campaigns.
© 2017 British HIV Association.

Entities:  

Keywords:  zzm321990HIVzzm321990; Eastern Europe; HIV serological assay; epidemiology; injecting drug users; recent HIV infection; recent infection testing algorithm

Mesh:

Year:  2017        PMID: 28762652     DOI: 10.1111/hiv.12535

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  8 in total

1.  How Can Progress Toward Ending the Human Immunodeficiency Virus Epidemic in the United States Be Monitored?

Authors:  Kate M Mitchell; Mathieu Maheu-Giroux; Dobromir Dimitrov; Mia Moore; James P Hughes; Deborah Donnell; Chris Beyrer; Wafaa M El-Sadr; Myron S Cohen; Marie Claude Boily
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

2.  Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort.

Authors:  Silvia Nozza; Alessandro Cozzi-Lepri; Francesca Bai; Stefano Rusconi; Andrea Gori; Paola Cinque; Adriana Ammassari; Pietro Caramello; Giuseppe Tambussi; Antonella D'Arminio Monforte; Giulia Marchetti
Journal:  PLoS One       Date:  2017-12-05       Impact factor: 3.240

3.  The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.

Authors:  Kristi Huik; Pilleriin Soodla; Merit Pauskar; S Michele Owen; Wei Luo; Gary Murphy; Ene-Ly Jõgeda; Eveli Kallas; Heli Rajasaar; Radko Avi; Silvina Masciotra; Irja Lutsar
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

4.  Epidemiological factors associated with recent HIV infection among newly-diagnosed cases in Singapore, 2013-2017.

Authors:  Li Wei Ang; Carmen Low; Chen Seong Wong; Irving Charles Boudville; Matthias Paul Han Sim Toh; Sophia Archuleta; Vernon Jian Ming Lee; Yee Sin Leo; Angela Chow; Raymond Tzer-Pin Lin
Journal:  BMC Public Health       Date:  2021-03-02       Impact factor: 3.295

Review 5.  A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications.

Authors:  Joseph Kin-On Lau; Nicholas Murdock; Jeffrey Murray; Jessica Justman; Neil Parkin; Veronica Miller
Journal:  J Virus Erad       Date:  2022-09-07

6.  Comparison between HIV self-testing and facility-based HIV testing approach on HIV early detection among men who have sex with men: A cross-sectional study.

Authors:  Yi Zhou; Shaoli Huang; Mingting Cui; Zhihui Guo; Haotong Tang; Hang Lyu; Yuxin Ni; Ying Lu; Yunlong Feng; Yuyu Wang; Fengshi Jing; Shanzi Huang; Jiarun Li; Yao Xu; Wenhua Mei
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

7.  Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.

Authors:  Sheila M Keating; Wes Rountree; Eduard Grebe; Andrea L Pappas; Mars Stone; Dylan Hampton; Christopher A Todd; Marek S Poniewierski; Ana Sanchez; Cassandra G Porth; Thomas N Denny; Michael P Busch
Journal:  PLoS One       Date:  2019-09-16       Impact factor: 3.240

Review 8.  Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.

Authors:  Shelley N Facente; Eduard Grebe; Andrew D Maher; Douglas Fox; Susan Scheer; Mary Mahy; Shona Dalal; David Lowrance; Kimberly Marsh
Journal:  JMIR Public Health Surveill       Date:  2022-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.